India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from Times of India https://ift.tt/39ZeN7J
via IFTTT
Subscribe to:
Post Comments (Atom)
England's massive win ends India's Australia tour euphoria
Beyond the cold numbers, the spell of magic cast by a 38-year-old Englishman will stay etched in the memories of those who managed to squeez...
-
The season of leaks in Indian women's cricket is in full bloom. The latest letter to have been leaked to media comes from India seamer ...
-
Malayalam actress Sona M Abraham’s rape scene uploaded on adult websites, accuses makers of ‘For Sale’ of leaking it from Entertainment ...
-
The 157-Test and 606-wicket veteran, England's proverbial 'old dog' James Anderson with a bite sharper than anyone else in their...
No comments:
Post a Comment